Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FLICE-inhibitory protein (FLIP) is a key negative regulator of apoptosis, particularly the extrinsic pathway triggered by death receptors. It exists in multiple isoforms (c-FLIPL and c-FLIPS) and functions by interfering with the formation of the death-inducing signaling complex (DISC), preventing caspase-8 activation. c-FLIP overexpression is associated with resistance to apoptosis in cancer and other diseases, making it a potential therapeutic target. Viral homologues (v-FLIPs) are used by viruses to evade host immune responses.
Inhibits apoptosis by interfering with the formation of the death-inducing signaling complex (DISC), preventing recruitment and activation of initiator caspases (mainly caspase-8). Acts as a dominant-negative inhibitor by blocking downstream signaling events.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FLICE-inhibitory protein (FLIP).